MEDIA, Pa., March 7 /PRNewswire-FirstCall/ -- Synova Healthcare, Inc., a wholly owned subsidiary of Synova Healthcare Group, Inc. , today announced plans to launch a new at-home test called Fem-V(TM). Fem-V is a non-invasive diagnostic test developed to assist women in diagnosing vaginal infections, and in determining the most appropriate treatment for these infections.
Today, the majority of women attempt to self-diagnose vaginal infections, while a diagnosis by a qualified healthcare professional occurs in only 30% of cases. Unfortunately today, there is very little awareness among women concerning the appropriate diagnosis and treatment of these types of infections. In fact, a Gallup survey cited by the National Vaginitis Association found that 95% of women surveyed had heard of yeast infections, but that only 36% had actually heard of the more common vaginal infection called bacterial vaginosis (BV); which can lead to serious medical complications. For example, there is strong and growing evidence that serious health risks associated with bacterial vaginosis include pelvic inflammatory disease (PID), as well as obstetric complications such as preterm labor and low birth weight babies.
For the millions of American women who experience vaginal infections annually, this easy-to-use at-home test will assist in determining the most appropriate treatment. Test results will help determine if an over-the- counter treatment may be considered, or if they should seek treatment from a healthcare professional. “Fem-V(TM) is the first over-the-counter, at-home vaginal infection test of its kind,” stated Chief Operating Officer, Mr. David Harrison. “It represents another innovative advance from Synova, and is part of our continued commitment to delivering innovative non-invasive medical diagnostics in women’s health care.”
Fem-V(TM) will be available in select pharmacy stores nationwide beginning later this spring.
About Synova Healthcare Group, Inc.:
-----------------------------------
Synova Healthcare Group, Inc. (SNVH) presently operates two wholly owned subsidiaries: Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc. The company distributes rapid, non-invasive medical diagnostics to retail for over-the-counter (OTC) use, and directly to health care providers for point of care (POC) use in the clinical setting. The company’s products are designed to improve human health and quality of life by providing early and accurate awareness of the onset of certain medical conditions.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “potential” and similar expressions. These statements reflect the Company’s current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Such risk factors are discussed in the Company’s Form SB-2 registration statement (File No. 333-123498), filed with the Securities and Exchange Commission on August 10, 2005, as well as in periodic reports filed with the Commission. There can be no assurance that such factors will not affect the accuracy of such forward-looking statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information set forth in this Press Release including such forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy; nor will there be any sale of securities of Synova Healthcare Group, Inc. in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.
Corporate Contact Information: Synova Healthcare Group, Inc. Attn: Mr. Robert Edwards, CFO 1400 N. Providence Road, Ste. 6010 Media, PA 19063 Tel: 610-565-7080 Fax: 610-565-7081 http://www.synovahealthcare.com Inquiries may also be directed to: info@synovahealthcare.com
Synova Healthcare Group, Inc.
CONTACT: Mr. Robert Edwards, CFO, Synova Healthcare Group, Inc.,+1-610-565-7080, or Fax: +1-610-565-7081, info@synovahealthcare.com
Web site: http://www.synovahealthcare.com/
